Multi-disciplinary Measurement of Host Biomarkers and Correlates in Infection and Immunity, Upcoming Webinar Hosted by Xtalks

Share Article

In this free webinar, the featured speaker will explain how fast-tracking the development of treatments and ensuring early selection of a promising one depends on the identification of significant immune correlates during both pre-clinical and clinical phases. Through case studies, the webinar will show the importance of a multi-disciplinary systems approach in the measurement of host biomarkers and immune correlates.

Xtalks Life Science Webinars

an appropriately detailed assessment of the host response will substantially inform the evaluation of antimicrobial prophylactics and therapeutics.

Understanding both pathogen and host, and their interactions, is essential to fully assess the effect of infectious diseases. The gold standard for diagnosis of an infection has been to demonstrate the presence of pathogen. However, disease severity, progression and the response to treatment are often more dependent on the status of the host. Therefore, an appropriately detailed assessment of the host response will substantially inform the evaluation of antimicrobial prophylactics and therapeutics.

The immune response is complex and collaborative. A robust immune response requires multiple cell lineages and soluble factors to work in concert. It is also influenced by multiple host factors including co-morbidities, levels of immune competence, type of response and age of the host. These factors are often meaningfully associated with specific at-risk populations and therefore need to be accounted for in development programs. All of these are risk factors associated with COVID-19 disease severity in high-risk groups. Age and immune function have also been shown to affect vaccination in general. Furthermore, the immune correlates of protection necessary for successful vaccine development may not be the same as those required for successful therapy development. A multi-disciplinary systems approach for the measurement of the host response is therefore required to successfully address all of these variables.

This presentation will support this argument by drawing examples from our extensive previous experience identifying infectious disease biomarkers in pre-clinical and clinical trial settings for diagnostic, disease progression or treatment response applications using a variety of platforms. The case studies will survey identification of predictive biomarkers of disease progression and response to vaccination, as well as cellular and soluble protein correlates of the vaccine response.

Join Eustache Paramithiotis, PhD, Vice-President, Research & Development, Caprion Biosciences Inc. in a live webinar on Friday, June 26, 2020 at 10am EDT (3pm BST/UK).

For more information or to register for this event, visit Multi-disciplinary Measurement of Host Biomarkers and Correlates in Infection and Immunity.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sydney Perelmutter
Xtalks
+1 (416) 977-6555 x 352
Email >
Visit website